Update on EGFR-mutated non-small cell lung cancer

Get full text

Immunotherapy insights from advanced disease /

Get full text
Series

The evolving role of novel and next generation therapies in the management of multiple myeloma part 1 of 2, introduction and current therapies /

Get full text

The evolving role of novel and next generation therapies in the management of multiple myeloma part 2 of 2, relapse refractory multiple myeloma /

Get full text

The role of exosomes in multiple myeloma development & drug resistance

Get full text
Series

A novel cancer therapy to stimulate oncogenic ERK signalling

Get full text
Series

Current challenges in the design of antibody-drug conjugates

Get full text
Series

Drug metabolizing enzymes in cancer therapeutics

Get full text
Series

Latest development in therapy-related autophagy research

Get full text
Series

Clinical research and care in the era of "N-of-1" precision cancer medicine

Get full text
Series

Mitochondrial inhibition as a novel therapeutic approach in drug-resistant cancer

Get full text

Overview of clinical pharmacology in cancer part 1 of 2 /

Get full text
Series

Key considerations for cancer pharmacotherapy part 1 of 2 /

Get full text
Series

Novel treatment options in lymphoma and leukemia part 1 of 2 /

Get full text
Series

Overview of clinical pharmacology in cancer part 2 of 2 /

Get full text
Series

Novel treatment options in lymphoma and leukemia part 2 of 2 /

Get full text
Series

Key considerations for cancer pharmacotherapy part 2 of 2 /

Get full text
Series

A systems approach to implementation of personalized cancer therapy

Get full text
Series (Cancer therapies in the personalized medicine era)
Series (Systems biology)

Case studies of adaptive early phase trials

Get full text
Series

Biomarkers and surrogate endpoints in randomized clinical trials

Get full text
Series